Abstract 6457: Phase I study of STA551 (STA) a tumor-selective CD137 agonist, as monotherapy and in combination with atezolizumab (atezo) using CD8 PET imaging to assess pharmacodynamic effects
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Udai Banerji, Diogo Silva, Joshua Ting, Zoulikha Zair, Prakash Manoharan, Toshihiko Doi, Shigehiro Koganemaru, Noboru Yamamoto, Takafumi Koyama, Seiichi Ikeda, Yuki Kanai, Michiyasu Inatani, Hitomi Takeshita, Akiko Hashimoto, Yoshitaka Ogita, Yuma Takano, Kei Higashikawa, Fiona Thistlethwaite
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148844849